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Abstract
Background: Remodeling of the extracellular matrix (ECM) has been implicated in ovarian cancer, and we
hypothesize that these alterations may provide a better optical marker of early disease than currently available
imaging/screening methods and that understanding their physical manifestations will provide insight into invasion.
Methods: For this investigation we use Second Harmonic Generation (SHG) imaging microcopy to study changes
in the structure of the ovarian ECM in human normal and malignant ex vivo biopsies. This method directly
visualizes the type I collagen in the ECM and provides quantitative metrics of the fibrillar assembly. To quantify
these changes in collagen morphology we utilized an integrated approach combining 3D SHG imaging
measurements and bulk optical parameter measurements in conjunction with Monte Carlo simulations of the
experimental data to extract tissue structural properties.
Results: We find the SHG emission attributes (directionality and relative intensity) and bulk optical parameters,
both of which are related to the tissue structure, are significantly different in the tumors in a manner that is
consistent with the change in collagen assembly. The normal and malignant tissues have highly different collagen
fiber assemblies, where collectively, our findings show that the malignant ovaries are characterized by lower cell
density, denser collagen, as well as higher regularity at both the fibril and fiber levels. This further suggests that the
assembly in cancer may be comprised of newly synthesized collagen as opposed to modification of existing
collagen.
Conclusions: Due to the large structural changes in tissue assembly and the SHG sensitivity to these collagen
alterations, quantitative discrimination is achieved using small patient data sets. Ultimately these measurements
may be developed as intrinsic biomarkers for use in clinical applications.
Background
In 2008, there were an estimated 21,650 new cases of
ovarian cancer in the United States and 15,520 deaths
(Cancer Facts and Figures 2008, American Cancer
Society, Database). Little is currently known about mar-
kers of premalignancy, early malignancy or early path-
ways for malignancy that could be potentially
manipulated for prevention or early detection of ovarian
cancer. Additionally, it is recognized that malignant cells
with a specific and identifying molecular fingerprint are
not always histologically identifiable in seemingly
normal epithelium adjacent to tumor[1,2]. Moreover,
certain subtypes of breast cancer are thought to carry
the necessary gene expression characteristics that pro-
mote very early metastasis at the time that they become
invasive[3], such that routine screening modalities will
fail to detect them early enough to impact survival. This
has also been suggested in high grade ovarian cancer
with metastasis occurring much earlier than previously
thought[4].
Thus there remains a compelling need for new tech-
nologies that have both sufficient resolution and speci-
ficity to detect microscopic tumors or precursor
lesions. Probing alterations in the ECM composition
and structure may be a promising approach in this
regard, as these changes are thought to be critical for
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carcinomas [5-7]. For example, up-regulation of several
proteases (e.g. MMP2, MMP9, and uPa) in ovarian
cancer have been implicated in invasion/metastasis
where these act by degrading the basement membrane
and/or stroma [8-13]. Additionally, in a feed-forward
mechanism, changes in the stromal compartment of a
tumor can then elicit a cascade of further changes
involving fibroblasts and tumor cells thereby generat-
ing more aggressive tumor cells [14,15]. We propose
that changes in the ECM may be a biomarker of inva-
sion and provide insight into the factors that facilitate
this process.
To investigate this possibility, we have explored the
use of high resolution (~0.5 microns) Second Harmo-
nic Generation (SHG) imaging microscopy[16] to
objectively quantify differences in tissue structure in
the ECM of normal and malignant ovarian tissues.
SHG is a coherent nonlinear process wherein two
lower energy photons are up-converted to exactly
twice the incident frequency (or half the wavelength)
of an excitation laser[17]. Like the more familiar two-
photon excited fluorescence microscopy, this modality
provides intrinsic optical sectioning and affords
enhanced imaging depths into tissues (up to a few
hundred microns)[18]. SHG does not utilize exogenous
stains and, due to the underling physics of the contrast
mechanism, directly visualizes the collagen assembly
and is sensitive to changes therein[16,18-21]. The pro-
cess results from a nonlinear polarization, rather than
absorption, where this is given by:
 
PE E  
() 2 (1)
where P is the induced polarization, E is the electric
field vector of the laser, and c
(2) is the second order
nonlinear susceptibility tensor of the collagen, and
whose magnitude determines the contrast level. Due to
the second order symmetry constraints imposed by Eq
1, the SHG contrast vanishes for assemblies with mirror
symmetry (i.e. centro-symmetric environment) and
increases for well-ordered structures[16]. Thus the rela-
tive alignment of fibrils/fibers is reflected in the magni-
tude of c
(2) which is experimentally manifested in the
SHG intensity. This tensor further contains information
on the alignment of the collagen molecules in the
fibrils/fibers[22]. Additionally, in contrast to fluores-
cence which is emitted at all angles, SHG has a well-
defined emission direction that carries information
related to the sub-resolution size and packing of the
fibrils and fibers [23-27]. In this paper, SHG signatures
of directionality, intensity, and polarization will be
exploited to show differences in the structure of the
ECM in normal and malignant human ovaries.
SHG has already been shown to have potential applic-
ability for cancer diagnosis by revealing changes in the
ECM in tumors relative to normal tissues. For example,
the Dong[28] and Pavone[29] labs used SHG to identify
tumor borders in basal cell carcinoma lesions by ima-
ging the collagen assembly. Similarly, in a mouse model
of breast carcinoma, Keely[30,31] identified distinct
stages of invasion by measuring changes of the angle of
collagen fibers with respect to tumor boundaries. Jain
also demonstrated that the increased collagen concen-
tration (i.e. desmoplasia) associated with a tumor from
implanted melanoma cells was measurable by SHG [32].
As fibrillar type I collagen is by far the major structural
element of the ovarian stroma, this modality may be
well-suited for probing morphological and structural
changes associated with early ovarian cancer. For exam-
ple, Kirkpatrick used combined SHG and fluorescence
imaging to show striking morphological changes in
malignant human ovarian biopsies[33].
Here we take a more general approach of quantifying
differences in the ECM of ex vivo normal and malignant
human ovaries by using SHG to measure or extract
changes in the respective fibril/fiber assemblies. The
quantitative approaches to be shown in this paper avoid
the pitfalls of empirical morphological assessments, and
additionally avoid the problems with pure signal inten-
sity based-measurements which can be confounded by
scattering. Indeed, the magnitude and directionality of
the scattering contains information on the tissue struc-
ture, which is encoded in the 3D SHG measurements
[19]. Together, we define the SHG emission directional-
ity (forward to backward ratio) and relative SHG inten-
sity (conversion efficiency based on c
(2))a st h eS H G
creation attributes. These, together with the bulk optical
parameters, are used in a comparative manner to quan-
tify differences in tissue structure in normal and dis-
eased ovary.
Methods
Tissue removal and preparation
The ovarian biopsies were removed using the University
of Connecticut Health Center IRB approved protocol
with patient consent prior to the procedure. The biop-
sies were removed and immediately fixed in 4% formalin
and refrigerated for 24 hours. These specimens were
then switched to PBS and kept at 4 degrees. For SHG
imaging and bulk optical parameter measurements, un-
stained sections of 100 and 50 microns, respectively,
were cut with a vibratome. Independent classification of
the ovary was based on histologic diagnosis of cancer (n
= 3) or no known risk factors for normal ovaries (n =
5). All of the cancers were high grade and late stage (III
or IV), although the tissue was harvested from the pri-
mary tumor in the ovary.
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The scattering coefficient μs, and scattering anisotropy,
g, are part of the metric to characterize the changes in
tissue structure in normal and malignant ovaries. The
inverse of μs is the mean free path (MFP), and is the
distance a photon will propagate before undergoing a
scattering collision and changing direction. This aniso-
tropy, g, is related to the directionality of the scattering,
and varies from 0 to 1. The upper limit corresponds to
highly forward-directed scattering and is reflective of
very highly ordered tissues, and 0 represents the isotro-
pic scattering associated with randomly organized struc-
tures. These bulk optical parameters (plus the
absorption coefficient μa) were determined at the 890
nm laser excitation wavelength using the titanium sap-
phire laser (see below) and the approximate SHG (457
nm Argon ion line) wavelengths using a dual integrating
sphere approach and angular resolved scattering mea-
surements as previously reported[19]. The refractive
indices were determined using the method of Li[34].
These parameters were then used in an inverse Monte
Carlo simulation[19,35,36] to calculate the absorption
coefficient μa and reduced scattering coefficient μs’
where:
   ssg () 1 (2)
SHG imaging system
The SHG imaging system has been described in detail
elsewhere and is only briefly described here[22]. The
instrument consists of a laser scanning unit (Fluoview
300;Olympus, Center Valley, PA) mounted on an
upright microscope stand (BX61, Olympus), coupled to
a mode-locked Titanium Sapphire femtosecond laser
(Mira; Coherent, Santa Clara, CA). All SHG imaging
was performed with an excitation wavelength of 890 nm
with an average power of ~20 mW at the specimen
using a water immersion 40× 0.8 NA objective. This
excitation wavelength was chosen to provide good depth
of penetration and also to exclude most of the poten-
tially confounding sources of two-photon excited auto-
fluorescence, which are predominantly excited at shorter
wavelengths. This wavelength and NA resulted in lateral
and axial resolutions of approximately 0.7 and 2.5
microns, respectively. Except for the polarization aniso-
tropy measurements where linear polarization was used,
SHG images were obtained using circularly polarized
excitation as this probes all fiber orientations equally.
The desired polarization at the focus was achieved as
previously described[37]. The microscope simulta-
neously collects both the forward (F) and backward (B)
components of the SHG intensity using identical cali-
brated detectors (7421 GaAsP photon counting
modules; Hamamatsu, Hamamatsu City, Japan). The
SHG wavelength (445 nm) was isolated with a 10 nm
wide bandpass filter (Semrock, Rochester, NY). 3D ren-
derings were performed with Imaris (Bitplane, Zurich
Switzerland).
3D SHG imaging measurements
The measured depth dependence of the forward-back-
ward intensity ratio (F/B) of the SHG signal is one
means to characterize structural changes in the ECM
between normal and malignant ovarian biopsies. This
axial response arises from a convolution between the
initial SHG directional emission ratio (which we denote
FSHG/BSHG) and subsequent SHG propagation through
the tissue which is based on μs and g at 445 nm. The
FSHG/BSHG is highly dependent upon the fibril diameter,
the packing density and regularity relative to the size-
scale of the SHG wavelength[23]. The bulk optical prop-
erties are related to density (primarily μs) and organiza-
tion (primarily g) of the fibrillar assembly. The
measured SHG directional (F/B ratios) values were
determined by integration of the intensity of 5-10
frames per optical section every few microns of depth
using ImageJ software http://rsb.info.nih.gov/ij/.
The measured attenuation, i.e. rate of intensity
decrease with increasing depth into tissue, of the for-
ward SHG signal is also used to characterize structural
changes in the ECM. The attenuation results from a
compounded mechanism of SHG creation attributes
(the FSHG/BSHG emission directionality and relative SHG
intensity) and primary filter effect (loss of laser intensity
due to scattering) and secondary filter effect (loss of
SHG signal). Since biological tissues have intrinsic het-
erogeneity in concentration, we have found a normal-
ized approach necessary to account for local variability
in SHG intensities in the same tissue (different fields)
and to make relative comparisons between tissues[19].
To this end the data of each optical series for each
biopsy is self-normalized to the optical section with the
average maximum intensity. The normalized forward
attenuation data was taken concurrently with the F/B
data. Like the directional data, these measurements are
quantitated using ImageJ by integration over whole
fields of view of the 40× lens.
Monte Carlo Simulations
The 3D SHG directional and attenuation measurements
are a convolution of the SHG creation attributes and
the bulk optical parameters. These contributing factors
are not directly determinable but can be decoupled by
u s i n gM o n t eC a r l os i m u l a t i o n s .T ot h i se n d ,w eh a v e
adapted the MCML framework[38] of photon propaga-
tion (absorption, scattering) to analyze the SHG axial
responses[19,39]. First, the transmission of the laser, at a
Nadiarnykh et al. BMC Cancer 2010, 10:94
http://www.biomedcentral.com/1471-2407/10/94
Page 3 of 14given focal depth, is determined based upon bulk optical
parameters at 890 nm, and the cone formed by the NA
of the lens. A relative SHG conversion efficiency, which
is proportional to the second order nonlinear suscept-
ibility c
(2) values for the different tissues, determines the
initial SHG intensity. An initial emission directionality,
FSHG/BSHG,i sa l s oa s s u m e d .T h ep r o p a g a t i o no ft h e
SHG signal (intensity and direction) is then calculated
using the measured bulk optical parameters at the SHG
wavelength. Collectively, by analyzing the trajectories of
50,000 photons at each focal depth, these steps simulate
the detected directionality (F/B) and attenuation as a
function of depth into the tissue.
Results
Assessment of morphological changes in the ECM by SHG
imaging
We first present qualitative evidence that SHG imaging
has the sensitivity and specificity to reveal distinct col-
lagen fibrillar assemblies in un-stained normal and
malignant ex vivo biopsies. The left panels in Figure 1a
and Figure 1b show respective SHG single optical sec-
tions from a normal ovary and a malignant tumor
arising within an ovary. Large morphological differences
in the collagen assembly are observed, where the fibers
are “cross-hatched” in the normal, where in contrast
they form highly regular helical structures in the tumor
specimens. Images from different regions of the same
normal ovary or the same tumor are characterized by
similar respective morphology, and in addition, the
morphologies displayed from tissues from different
patients of each type are also similar.
To place these images in context, we compared them
to standard H&E histopathology cross sections (5
microns thick) from the same respective biopsy. The
middle and right panels of Figure 1 show representative
results for forward detected SHG and two-photon
excited fluorescence (TPEF)f r o mt h e s es e c t i o n s .T h e
staining does not contribute to the SHG contrast, which
arises from the collagen itself. The SHG images from
the histological preparations do not appear the same as
the left panel which showed en face optical sections
from thicker tissue slices. Still, different fibrillar assem-
blies are observed in cross section as well. The TPEF
channel primarily arises from eosin which stains essen-
tially all proteins, which in the stroma is predominantly
Figure 1 Representative SHG and TPEF images from normal (a) and malignant (b) ovarian biopsies. The left panels are en face SHG
images of single optical sections where the tissue thickness was ~100 microns; the center and right images are SHG and TPEF images
respectively from H&E optical sections from the same tissue as used for the en face images. Scale bar = 25 microns.
Nadiarnykh et al. BMC Cancer 2010, 10:94
http://www.biomedcentral.com/1471-2407/10/94
Page 4 of 14type I collagen. Thus for both the normal and cancer
cases the TPEF from eosin and SHG reveal the same
respective overall image features. However, the eosin
contrast is less well-defined, which is likely a conse-
quence of the sensitivity of SHG to fibril/fiber assembly,
where, in contrast, there are no symmetry constraints
on the fluorescence. This overlap gives us confidence
that we can look at similar features by SHG as by histol-
ogy, and, as we will show below, with enhanced infor-
mation content. In addition, the ability to image intact
thicker tissues in situ (100-200 microns) by SHG allows
for the acquisition over more fields of view than is prac-
tical by conventional histology.
Next, we compare 3D renderings of SHG images with
histological cross sections from the same biopsies (for
both normal and malignant tissues) to examine the
respective cell content and corresponding spatial distri-
bution in the ECM (Figure 2). This is an important
characterization as cells are transparent in SHG con-
trast, whereas the hematoxylin and eosin visualizes the
cell nuclei and protein content respectively. Compared
to the normal tissue (Figure 2, top), the cancer (Figure
2, bottom) is highly a-cellular away from the surface
epithelium, consisting almost exclusively of dense col-
lagen. This densely packed structure is also apparent in
the 3D SHG rendering showing tightly packed helical
fibrils (as also seen in the single optical section in Figure
1). By contrast, the normal tissue is less tightly woven,
where the spaces accommodate stromal cells. We will
show below that changes in collagen content between
Figure 2 3D SHG renderings (left panels) and H&E staining (right panels) of normal (top) and malignant ovarian biopsies (bottom).
The field size for the 3D renderings was 170 microns and the histology cross sections were captured at 40×.
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in conjunction, through 3D SHG imaging and bulk opti-
cal parameter measurements.
Bulk optical parameter measurements
The large difference in fiber morphology and collagen
packing in malignant biopsies observed in both the SHG
and H&E histology images suggests that the scattering
coefficient and scattering anisotropy may be different
than that of the normal tissue. The bulk optical para-
meters (μs, μs’, μa, and g) for the normal and malignant
tissues at the laser (890 nm) and SHG (457 nm) wave-
lengths are given in Table 1 and the associated p values
from two sided t-tests are shown in Table 2. For both
tissues at both wavelengths, absorption (μa)i sn e g l i g i b l e
(~25-50 fold smaller) compared to scattering (μs)a n d
we therefore we have focused our attention on the lat-
ter. The malignant tissues are more highly scattering at
the SHG wavelength compared to the normal (267 vs
172 cm
-1) where this difference was significant (p =
0.008). We interpret the higher scattering of the cancer
to be indicative that the matrix is more densely packed
than the normal tissue, resulting in a smaller MFP. This
conclusion is also borne out by inspection of the SHG
renderings and H&E staining (Figure 2). We point out
that these measurements were on fixed tissues, where
the procedure will alter the absolute values of the scat-
tering coefficient. However, previous EM studies have
shown that fixation does not significantly alter the fibril-
lar structure and only results in a slight reduction in
volume (~20%)[40]. We have also compared SHG
images of fully hydrated and fixed specimens of tendon
and skin, and found that the fibrillar morphology was
similar with comparable associated shrinking (un-pub-
lished data). We further note that in this analysis we are
making comparisons between two tissues, where both of
which would be similarly affected by the fixation
procedure.
The scattering anisotropy values for the normal and
malignant tissues at 890 nm and 457 nm and corre-
sponding t-tests are shown in Tables 1 and 2, respec-
tively. The g values are statistically different at the laser
890 nm wavelength (0.94 vs 0.86; p = 0.002) but are not
different at the SHG wavelength (p = 0.4). We stress
t h a tt h em e a s u r e dgv a l u e sa r et ob ec o n s i d e r e de f f e c -
tive, as the 50 micron thick biopsies can support ~1
scattering event (based on μs), thus the actual values
might be somewhat higher. However, as we have not
extracted different values for ovarian tissues of 50 or
100 μm in thickness, we do not believe this to be a sig-
nificant effect. This was also shown to be valid in prior
work on dermis[19]. Moreover, the measurements are
used for comparative analysis between the tissues, and
as they were performed in a consistent manner, small
absolute errors do not affect the following spectral data
interpretation or subsequent Monte Carlo simulations.
While not all the respective μs and g values for the
normal and malignant tissues were different at the laser
and SHG wavelengths, we first note that the redcued
scattering coefficient μs’ was different at both wave-
lengths (890 nm, p = 0.0004; 457 nm, p = 0.02). Addi-
tionally, the spectral dependence or spectral slope[41] of
μs’ was different where the malignant and normal tissues
were characterized by a 1.5 and 3 fold respective
increase in μs’ between the laser wavelength and SHG
wavelengths. This flatter spectral slope for the more
ordered malignant tissue (exemplified by highly periodic
helical fibrils compared to the more randomly appearing
normal tissue) is predicted by the recent theoretical
treatment by Backman [42]. We have also seen this
result in measurements on tendon, which has similar
regularity[39]. Thus the spectral dependence of μs’ pro-
vides one piece of quantitative evidence of the change in
tissue structure that occurs during ovarian cancer.
These bulk optical parameters are also incorporated in
Monte Carlo simulations of the depth dependent SHG
directionality and attenuation shown below.
SHG directional measurements
The measured forward-backward intensity ratio (F/B)
arises from a convolution between the SHG directional
emission creation ratio (FSHG/BSHG) and subsequent sig-
nal propagation through the tissue based on μs and g at
the SHG wavelength. The averaged experimentally mea-
sured F/B vs depth plots for normal (n = 5) and malig-
nant ovaries (n = 3) are shown in Figure 3. At all depths
below the surface epithelium the SHG from the normal
tissues are more forward directed than the cancers,
which is consistent with the lower scattering coefficient
of the former (172 vs 267 cm
-1), such that photons that
Table 1 Measured bulk optical parameters at the SHG
and fundamental wavelengths with standard deviations.
Cancer n = 3
457 nm
Cancer
890 nm
Normal n = 5
457 nm
Normal
890 nm
μs (cm
-1) 267 ± 19 195 ± 26 172 ± 39 161 ± 43
μa (cm
-1) 6.3 ± 3.1 6.6 ± 1.5 7.3 ± 2.4 5.6 ± 1.2
g 0.82 ± 0.02 0.86 ± 0.02 0.83 ± 0.01 0.94 ± 0.01
μs’ (cm
-1) 46.2 ± 2.0 29 ± 3.3 29.6 ± 6.5 10.3 ± 3.8
Table 2 p values for the measured bulk optical
parameters at the SHG and fundamental wavelengths
Wavelength μs μa g μs’
890 nm 0.267 0.29 0.002 0.0004
457 nm 0.008 0.62 0.40 0.02
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continuing to propagate in this direction. To validate
the distinction between these tissues t-tests were per-
formed at 10 micron depth intervals, and the differences
were statistically significant (p < 0.01 in all cases).
We also observe that for both tissues the F/B increases
with increasing depth into the tissue. This result is con-
sistent in the framework of photon diffusion theory,
where at least one transport MFP is required between
the location of the emitted photon and the forward
boundary of the specimen for efficient multiple scatter-
ing to occur[38]. Thus as the distance from the focal
point to the tissue boundary shortens, the probability of
multiple scattering events decreases and the F/B ratio
subsequently increases.
We utilized Monte Carlo simulations of these plots
using the measured bulk optical parameters at inputs to
decouple the initial emission directionality (i.e. FSHG/
BSHG) from the SHG propagation (based on μs and g).
To estimate this creation attribute we ran simulations
varying the forward emitted fraction (FSHG)f r o m5 0 -
100%. Representative simulations for the normal and
malignant biopsies are shown in Figure 4a and 4b,
respectively, which demonstrate the pronounced effect
the initial directionality has on the measured F/B. We
then fit to the initial directionality by squaring and
summing the residuals between the series of simulations
and the experimental data. Taking the minimum of the
R
2 function yielded %FSHG of 93% and 77%, for the nor-
mal and cancer, respectively, where the uncertainly in
each case is approximately ± 3%. The corresponding
Monte Carlo simulation generated from the best fit for
each tissue type (open squares = normal and open cir-
cles = cancer) are overlapped with the experimental
SHG data in Figure 4c. The Chi-squared test between
the experimental and simulated data resulted in values
of 0.40 and 0.30 for the normal and cancer respectively,
indicating that, for both tissues at the a = 0.05 level, the
differences between the data and corresponding simula-
tion are not significantly different. This good fit between
the simulated and measured data thus gives us confi-
dence in the extracted %FSHG values.
The SHG emission directionalities between the tissues
are significantly different and can be interpreted by the
difference in fibril assembly. Using a space filling analy-
sis of TEM images we found that the packing of the
fibrils in the malignant tissue to be more regular relative
to the normal (10% vs 15% inter-fibrillar space respec-
tively). Based on our mathematical model of SHG in
fibrillar tissues,[23] the fibril assembly of the malignant
tissue, i.e. regularly packed fibrils on the order of the
coherence length, would give rise to efficient backward
Figure 3 Averaged measured forward/backward SHG intensities as a function of depth for normal (blue circles) and malignant (red
squares) ovaries.
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Page 7 of 14Figure 4 Monte Carlo Simulations of the measured F/B response, where (a) and (b) show the results for normal (a) and malignant (b)
ovaries using the bulk optical parameters in Table 1 over a range of initial emission distributions. The best fit simulation to the data in
each case is overlapped with the experimental data in (c), where the %FSHG was determined to be 77% and 93% for the malignant and normal
tissues, respectively.
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bly in the normal would result in more predominantly
forward initial emission directionality (i.e. higher %
FSHG), as was extracted from the simulation of the data.
SHG attenuation measurements
The averaged normalized forward attenuation data with
standard errors are shown in Figure 5a for the normal
(n = 5) and malignant (n = 3) tissues. Unlike the F/B
response, the SHG attenuation provides no clear separa-
tion between the tissues. To understand this effect, we
need to consider all the factors that give rise to the
measured attenuation. This results from a compounded
mechanism of the FSHG/BSHG emission directionality,
the relative SHG intensities governed by the relative
magnitudes of the c
(2) nonlinear susceptibility tensors,
and primary and secondary filter effects from the
respective bulk optical properties. As we have previously
reported,[19] it is not possible to directly determine
relative c
(2) values in intact tissues as the measured sig-
nal is convolved with scattering when the tissues are
t h i c k e rt h a no n eM F Po r~ 5 0m i c r o n s .H o w e v e rt h i s
can be achieved using much thinner histological sections
(~5 microns). We note that the eosin staining does not
Figure 5 Forward SHG attenuation data and simulations for normal and malignant ovarian biopsies. 5(a) shows the experimental data
for normal (blue squares) and cancer (red circles). 5(b) shows the experimental data (closed circles and squares) every 10 microns and the
simulations (open circles and squares) based on the measured bulk optical parameters in Table I and the relative c
(2) values that were
determined from the histological sections.
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relative SHG intensities from these sections yields a fac-
tor of 3.9 ± 0.1 (p < 0.005) increased brightness for the
cancer over that of normal tissue.
We now use all our measured factors as inputs into
Monte Carlo simulations of the SHG attenuation. The
simulated data for the normal (open squares) and malig-
nant tumors (open circles) based on the bulk optical
parameters (see Table 1) and the relative c
(2) values are
shown in Figure 5b. Like the experimental data, the
simulations are highly similar for these two tissues.
However, the rate of decay of the simulated SHG inten-
sity is somewhat greater for the experimental data,
where the differences are most pronounced at the bot-
tom of the slice. While an exact match was not obtained
this approach still allows us to understand the similarity
in the measured data for these tissues. This similarity
arises from the offsetting parameters of the increased
conversion efficiency (c
(2)) and larger μs for the cancers,
as these separately would result in slower and faster
normalized attenuations, respectively. We point out if
the relative SHG conversion efficiencies were not inde-
pendently known, this approach would allow this deter-
mination once the respective bulk optical parameters
were measured at the laser excitation and SHG wave-
lengths. This would be accomplished by running simula-
tions varying the relative conversion efficiency and then
comparing the results to the experimental data to
achieve the best fit (in analogy with the method pre-
sented on the directional data).
Discussion
SHG imaging to measure changes in tissue structure
Our goal in this work was to develop SHG imaging
and analysis metrics that can be used to understand
changes in ECM structure during carcinogenesis and
eventually be utilized in clinical applications. The
enabling aspects of SHG for tissue characterization lie
not solely in the ability to visualize the fibrillar mor-
phology, but also in the contrast being reflective of the
supramolecular and fibrillar structure of collagen
[16,18]. These differences in structural features cannot
be resolved by optical microscopy methods but they
are manifested in terms of the relative SHG intensities
(i.e. c
(2) values) and initial emission directionality
(FSHG/BSHG). For example, these creation attributes
depend on packing density and order of the inter-fibril
structure, both of which change in cancer (Figure 1).
Monte Carlo simulation of the 3D SHG responses
incorporating the bulk optical parameters allows the
isolation of these attributes and provides insight into
the tissue assembly. For example, the directional mea-
surements are most sensitive to FSHG/BSHG which is
related to the fibril size and packing, and was different
for both tissues. By contrast, the attenuation measure-
ments are not appreciably affected by this term but are
highly sensitive to the relative c
(2) values, which are
related to collagen concentration and assembly, which
was also different for both tissues. The directly mea-
sured or extracted SHG attributes or bulk optical
properties that are different for the normal and malig-
nant ovaries along with the physical interpretation are
summarized in Table 3. In contrast, in our prior work
we showed that when Osteogenesis imperfecta (a con-
nective tissue disorder arising from abnormal collagen)
skin was compared to the normal, a different set of
parameters was found to differentiate them[19]. Thus
the depth dependent directionality (F/B), the attenua-
tion measurements, bulk optical parameters, and corre-
sponding simulations represent a versatile means for
characterizing changes in tissue structure occurring in
diseases in which collagen alterations occur.
While the attenuation measurement did not provide
clear discrimination between the normal and malignant
tissues, we can better understand the measured data
through the use of simulations. We note that in the can-
cer biopsies, the tumor extensively replaced the ovary
(near the surface) and it is possible there could be dis-
crimination in earlier stage disease, where both the SHG
and bulk optical parameters could likely be different due
to different levels of ECM remodeling. Specifically, we
predict that earlier stage tumors would be characterized
by decreased scattering and SHG brightness relative to
the latter stage tumors imaged here. Moreover, even for
these tissues, the attenuation response at other wave-
lengths may provide discrimination due to the differ-
ences in the spectral slope of μs’ (see Table 1 of bulk
optical properties).
Table 3 Summary of structural properties different in normal and malignant ovaries
μs (457 nm) (cm
-1)
density
Refractive index correlation
function
SHG emission
(%forward)
Fibril packing
Into fibers
SHG Intensity (relative)
Concentration and
organization
SHG anisotropy
Fiber organization
Normal 172 ± 39 Mass fractal 93% 1 0.76
Cancer 267 ± 19 Stretched exponential 77% 3.9 0.88
Conclusion Cancer denser Cancer more ordered Cancer better packed
fibrils
Cancer denser and more
organized
Cancer more
organized
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Collectively, the SHG creation attributes, bulk optical
parameters, and cell density (by H&E histology) suggest
that a profound alteration of the ECM occurs in ovarian
cancer. An unanswered and important question is if this
structure represents remodeled existing collagen or new
synthesis by the stromal cells, or both. There is signifi-
cant translational importance to this question as it
addresses the temporal evolution of invasion. To begin
to address this question, we first note that the SHG
intensity was nearly 4 fold greater in the malignant
ovary, suggesting the collagen was both higher in abun-
dance and more organized. We have investigated the
fibril size and packing using TEM and found similar size
distributions of fibril diameter in the normal and malig-
nant biopsies, where the most probable diameter was
~80 nm. However, the fibrils in the tumor are more clo-
sely packed, which would result in a greater SHG
intensity.
We can next assess the regularity of the collagen fiber
alignment by measuring the SHG anisotropy. This ani-
sotropy, b, is calculated by:
 


Ipar Iperp
Ipar Iperp 2
(3)
where Ipar and Iperp correspond to the SHG intensity
detected after a polarizer oriented parallel and perpendi-
cularly to the laser polarization, respectively. Here the
linear polarization of the laser is fixed at 45 degrees
relative to the fiber axis (on a fiber by fiber basis) and
then the SHG parallel and perpendicular components
are measured relative to this excitation polarization. We
chose this angle because this orientation yields the
strongest SHG intensity for collagen[22]. Values of b
vary from -0.5 to 1 where 0 represents completely ran-
dom organization and 1 represents completely ordered
fibers. We have acquired polarization analyzed data
from forward SHG and calculated b values of 0.88 and
0.76 for the malignant and normal ovary, respectively,
where representative analyzed optical sections are given
in Figure 6. The higher b for the cancer corresponds to
greater fiber alignment, where this assembly would also
yield brighter SHG, as was observed through imaging of
the thin sections.
While this issue warrants much further investigation,
the existing data based on similar fibril diameter (based
on TEM) and increased fibril/fiber organization supports
the argument that the collagen beneath the surface
epithelium is more likely to be newly synthesized as
opposed to existing collagen fibrils being remodeled by
proteases. This is also indicated by the spectral depen-
dence of μs’ between the laser excitation and SHG
wavelengths. Using the formalism of Backman,[42] we
find that the normal and malignant tissues are charac-
terized by different refractive index correlation func-
tions. The malignant tissue is characterized by a
stretched exponential function, where the scattering
objects are similar in size[42]. The normal tissue falls
within the mass fractal regime, which is best described
as having only characteristic length scales over which
there is similarity in the refractive index, rather than
typical scattering sizes. In sum, based on the separate
scattering and SHG measurements, it would appear
unlikely that less ordered collagen in normal stroma
could be transformed into a more ordered structure in a
tumor.
Comparison to fluorescence microscopy
We have achieved statistical discrimination in the mea-
sured F/B directional data based on a small data set of
normal and malignant ovaries because the optical signa-
tures are profoundly different in these tissues but homo-
geneous within each type. Moreover, the SHG creation
attributes and bulk optical properties are consistent with
the differences in fibrillar assembly between the tissues
based on the morphology observed by H&E, and EM.
By contrast, inherent variability and non-specificity in
modalities such as fluorescence precludes this definitive
distinction. For example, a previous paper on ovarian
cancer found significant heterogeneity between diagnos-
tic groups arising from innate tissue variations[43]. The
authors concluded that fluorescence measurements at
several different wavelengths were required for charac-
terization, and that larger numbers of patients were
needed to develop this modality as a robust imaging
tool based. In fact, because of this heterogeneity, fluor-
escence imaging (especially of metabolism) is now more
commonly being combined with other modalities to
improve the specificity of optical measurements for
many epithelial cancers including ovarian[33]. We did
not find this degree of variability present in our small
study, which implies that the specific signal that SHG
measures has far less heterogeneity than would be
expected from fluorescence data alone. This may arise
as SHG only probes the collagen assembly, whereas the
autofluorescence can arise from many components. We
note that while collagen autofluorescence has been
detected spectroscopically from tissues, is typically too
weak to be useful for microscopic imaging.
Outlook
Through this exploratory study derived from a basic
science perspective we have identified a collection of
physical/structural properties of the ECM that change
when the ovary becomes malignant. This characteriza-
tion was enabled by the high sensitivity/specificity of
Nadiarnykh et al. BMC Cancer 2010, 10:94
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use these structural changes in the ECM as a specific
biomarker in vivo. While at the 890 nm excitation wave-
length there was no discrimination between normal and
diseased ovary in the forward attenuation data, this may
be different at other wavelengths due to the spectral
slope differences (i.e. from the different refractive index
correlation functions) as well as different stages of dis-
ease. Moreover, performing these measurements in the
backward collection geometry would yield all the same
data as shown here in the forward case. With our cur-
rent technology, the directional measurements cannot
be performed in vivo, however given the rapid advances
in fiber-optics and miniaturized scanning devices we
envision that a multiple probe scheme could be con-
structed where the same information could be extracted.
We note that the directional measurements could be
applied to ex vivo biopsies of more accessible epithelial
tissues such as skin and breast, where ECM remodeling
also accompanies carcinogenesis.
Conclusions
We have performed an exploratory study to understand
and quantify changes in tissue structure that occur dur-
ing ovarian carcinogenesis. In this effort we have identi-
fied optical signatures (SHG creation attributes and bulk
optical parameters) that are different between normal
and malignant ovarian tissues and have established their
Figure 6 SHG anisotropy measurements of cancer (a) and normal (b) ovary, where the left and right panels are images acquired with
a polarizer parallel and perpendicular to the laser polarization, respectively. Field size = 170 microns.
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directional and attenuation responses are consistent
with the differences in tissue structure at both the fibril
and fiber levels of assembly. The increased order of the
fibril/fiber assembly suggests that in the malignant tis-
sues that the collagen has been newly synthesized. We
find using surprisingly small patient data sets that our
methods provide statistical discrimination between nor-
mal and malignant ovarian biopsies in terms of the SHG
creation attributes as well the bulk optical parameters,
pointing to the specificity of the approach. We antici-
pate that the methods will prove valuable in terms of
better investigating changes in the ECM structure which
will impact our understanding of early disease. We lastly
suggest that SHG imaging may become a powerful tool
for future diagnostic applications as an early biomarker
for the ovary and potentially other epithelial cancers.
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